title: Recent Changes in Chronic Kidney Disease-Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation.
abstract: The management of chronic kidney disease-mineral and bone disorders has recently changed. We investigated the modifications of chronic kidney disease-mineral and bone disorder with a special focus on the incidence of fractures in the first year after kidney transplantation (KT).
  
  
  
  We retrospectively compared 2 groups of patients who consecutively underwent transplantation at our center 5 years from each other. Group 1 consisted of patients (n = 152) transplanted between 2004 and 2006, whereas patients in group 2 (n = 137) underwent KT between 2009 and 2011.
  
  
  
  During the end-stage renal disease phase at the time of transplant, cinacalcet, and native vitamin D were used significantly more frequently in group 2. Median intact parathyroid hormone levels were lower and severe hyperparathyroidism decreased significantly. Vitamin D deficiency dropped from 64% to 20%. After transplantation, persistent hyperparathyroidism (parathyroid hormone > 130 ng/L) and bone turnover markers were significantly reduced in group 2. Native vitamin D supplementation increased over time, whereas the use of active vitamin D was unchanged. The 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels were significantly higher. The fracture incidence at 1 year decreased significantly (3.1% vs 9.1%; P = 0.047). No steroid sparing was observed in group 2. Bisphosphonates after KT were more frequently used in group 2.
  
  
  
  Recent changes in clinical practice are associated with reductions in pretransplant and posttransplant hyperparathyroidism, vitamin D deficiency, and fracture risk after KT.
authors.affiliation: 1 Nephrology-Transplantation Department, University Hospital, Strasbourg, France. 2 Rheumatology Department, University Hospital, Strasbourg, France.
authors.forename: Peggy
authors.initials: P
authors.lastname: Perrin
authors.forename: Clotilde
authors.initials: C
authors.lastname: Kiener
authors.forename: Rose-Marie
authors.initials: RM
authors.lastname: Javier
authors.forename: Laura
authors.initials: L
authors.lastname: Braun
authors.forename: Noelle
authors.initials: N
authors.lastname: Cognard
authors.forename: Gabriela
authors.initials: G
authors.lastname: Gautier-Vargas
authors.forename: Francoise
authors.initials: F
authors.lastname: Heibel
authors.forename: Clotilde
authors.initials: C
authors.lastname: Muller
authors.forename: Jerome
authors.initials: J
authors.lastname: Olagne
authors.forename: Bruno
authors.initials: B
authors.lastname: Moulin
authors.forename: Sophie
authors.initials: S
authors.lastname: Ohlmann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D050071:Bone Density Conservation Agents; D014807:Vitamin D